The research contributions of UNSW PhD student Dr Adeniyi Borire have been recognised by the American Association of Neuromuscular and Electrodiagnostic Medicine.
A drug that lowers blood sugar levels for people with type 2 diabetes has been revealed to also significantly reduce the risk of both cardiovascular and kidney disease.
